April 2016

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates


Ongoing All Ranks Non-federal Culture of Health

Robert Wood Johnson Foundation (RWJF)
Evidence for Action: Investigator-Initiated Research to Build a Culture of Health

Development of data and evidence needed to advance a Culture of Health.  Research could: (1) Provide evidence for factors in the Action Framework that are believed - but not yet proven to impact health; (2) Reframe or challenge existing ideas; (3) Integrate existing data and methods across disciplines and sectors; and/or (4) Identify actions that can improve health for marginalized populations.
Due Dates: Applicants can expect notification w/in 6-8 weeks of a 2-page Letter of Intent submission. Invited applicants will have 2 months to submit a proposal. Funding decisions will generally be made within 6-8 weeks of the full submission.
Amount & Project Period: ~$200,000 - up to 30 months
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι 2015 Call For Proposals

Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding.
Due Dates: Open until Mar. 31, 2017
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: ARO CORE BAA-W911NF-12-R-0012-Mod 03


Ongoing All Ranks Federal See BAA

United States Army Medical Research and Materiel Command (USAMRMC) Broad Agency Announcement for Extramural Medical Research
W81XWH-16-R-BAA1

The mission of the USAMRMC is to provide solutions to medical problems of importance.  Projects must be for basic and applied research. Projects must be for scientific study and experimentation directed toward advancing the state of the art or increasing knowledge or understanding.  (See general description of research and development programs, including research areas of interest in the announcement.)
Due Dates: Open continuously from Oct. 01, 2015 through Sept. 30, 2016. Organizations are required to submit pre-proposals/pre-applications. 
Amount & Project Period: Budgets are not limited - up to 5 years
Eligibility: All individuals, regardless of ethnicity, nationality, or citizenship status, employed by, or affiliated with, an eligible organization.
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-16-R-BAA1


Rolling All Ranks Non-federal Pediatric

Thrasher Research Fund
E.W. "Al" Thrasher Awards

Ideal applications address significant health problems that affect children in large numbers and offer the potential for practical solutions to these problems.  Such solutions sh/be innovative and have potential for broad applicability w/low financial and/or technical barriers to implementation.  Hypothesis-driven research is preferred over exploratory, hypothesis-generating research. Projects with a shorter distance to clinical applicability are given priority.
Due Dates: Concept papers accepted on a rolling basis, and time from submission to decision is 1-6 weeks.  Submission of full proposal is allowed up to 1 year after approval of concept.  Review and response on proposal can take about 4 months.  Proposals and reviews are submitted to Committees at the beginning of February and August and final decisions are made in late March and late September.  For a September decision, concept papers should be submitted in April to allow sufficient time for the process.
Amount & Project Period: Grant amount is based on the actual budgetary needs of the project - Up to 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview and Guidance


March 21 All Ranks Non-federal Cancer Biology

Human Frontier Science Program (HFSP)
Young Investigators' Program & Program Grants

The HFSP funds basic research. The aim is to support teams of scientists at the forefront of research in their respective areas, whose collaborative projects open up new frontiers in fundamental biology.  Funding ranges from the biomolecular level to studies of whole organisms.
Due Dates: Mar. 21(for registering & obtaining a reference number)
Mar. 31 (Letter of Intent)
Amount & Project Period: $250,000/yr. (team of 2); $350,000/yr. (team of 3); $450,000/yr. (team of 4 or more) - 3 years.  Please see guidelines for detailed information on funding requirements.
Eligibility: Young Investigator - All team members must be w/in 5 years of obtaining independent position, and  have obtained first doctoral degree (PhD, MD or equivalent) <10 years before deadline for submission of the letter of intent.
Program Grants  - Team members will be independent researchers at any career stage.
Common to both Grants - Must organize an "international research team"(w/emphasis on intercontinental collaborations).
Contact: Office of Sponsored Research (x6804)
Links: Research Grants Ι Information & Guidelines Ι Submission Site


March 21 (LOI) All Ranks Non-federal Healthcare/Vulnerable Populations

Rita & Alex Hillman Foundation
Innovations in Care

The goal of this program is to advance leading edge, nursing driven models of care that will improve the health and health care of vulnerable populations that encounter barriers to accessing health-care services.  Bold, evidence-based, patient- and family-centered approaches that challenge conventional strategies, improve health outcomes, lower costs, and enhance patient and family caregiver experience are sought in 3 areas of interest:  Maternal & Child Health, Care of the Older Adult, and Chronic Illness Management.
Due Dates: Mar. 21 (Letter of Intent)
Invited Submissions: June 18 (OSR) Ι June 20 (Sponsor)
Amount & Project Period: $600,000 (TOTAL) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι RFP


UPDATED DUE DATES
March 27 Junior Faculty/Postdocs Non-federal Career Development

American Society for Radiation Oncology

Due Dates: Mar. 25 (OSR) Ι Mar. 27 (Sponsor)
Contact: Office of Sponsored Research (x6804)
 

Junior Faculty Career Research Training Award

 Specific areas of interest may include:
1. Basic and clinical research in radiation therapy sciences;
2. Projects developing innovative techniques, new methods or special equipment leading to better patient care;
3. Aspects of health care planning and delivery, including outcome evaluation;
4. Development of programs in health education relevant to radiation therapy sciences.
Amount & Project Period: $100,000/yr. - 2 years
Eligibility: Must be board-eligible physician or physicist in radiation
oncology or a radio-biologist w/in first 3 years of junior faculty appointment;
Applicants & mentors must be active ASTRO members;
At least 75% full-time effort must be devoted to goals of award.
Link: Guidelines
 

Residents/Fellows in Radiation Oncology Research Seed Grant

This award is designed to support residents or fellows who are planning a career focusing primarily on basic science or clinical research in radiation oncology.
Amount & Project Period: $25,000 - 1 year
Eligibility: Postdocs/Residents
Must name a primary mentor or co-mentor (All mentors must be active members of ASTRO).                        
Must commit at least 75% full-time professional effort to the goals of this award.
Link: Guidelines


March 29 (Pre-app) All Faculty Federal Bone Marrow Failure (BMF)

Congressionally Directed Medical Research Programs (CDMRP)
Bone Marrow Failure Research Program
Idea Development Award

Will fund scientifically meritorious research focused on BMF syndromes. Investigator-initiated research is encouraged in the areas of congenital or acquired BMF.  Studies focused on BMF syndromes and their progression to other malignancies, such as leukemia, are acceptable.  However, research primarily focused on myeloproliferative neoplasms, leukemia, or other malignancies is discouraged. Stem cell biology studies and translational projects including bone marrow transplantation studies should be clearly related to BMF syndromes.
Due Dates: Mar. 29 (Pre-application)
Invited Submissions:  July 11 (OSR) Ι July 13 (Sponsor)
Amount & Project Period: $315,000 (Direct Costs) - 2  years
Eligibility: Open to established (EI) and early career investigators(ECI). Investigators at or above the level of Associate Professor (or equivalent) are eligible to apply as EIs.
Investigators at the level of Assistant Professor, Instructor, or Assistant Research Professor (or equivalent) and less than ten years from terminal degree (excluding time spent in medical residency, or during family medical leave) at time of application submission deadline are eligible to apply as ECIs. Time spent as a postdoctoral fellow is not excluded and must be within the 10-year span from the time of terminal degree. Postdoctoral fellows are not eligible for the designation of ECIs.
Contact: Office of Sponsored Research (x6804)
Links: W81XWH-16-BMFRP-IDA | https://eBRAP.org (pre-app. portal)


FINAL DUE DATE FOR THIS SUPPLEMENT
March 30 All Ranks Federal Diversity Supplements

P30-R25 Continuing Umbrella of Research Experience (CURE)
Clarification

NIH/NCI is currently accepting applications for P30 CURE Supplements during the submission period of February 1 - March 30, 2016.  This is the last submission period for P30 CURE Supplements.   All Cancer Centers are encouraged to apply.
The anticipated R25 YES FOA is expected to be published in the summer of 2016, with the first submission deadline in the fall of 2016.  All Cancer Centers, with or without active P30 CURE Supplements, are encouraged to apply.  
The anticipated R25 YES FOA does not affect currently active P30 CURE Supplements. All P30 CURE Supplements may continue until the originally awarded period finishes.  Cancer Centers with active P30 CURE Supplements are especially encouraged to apply for the anticipated R25 YES FOA in order to continue the P30 CURE programs.  If an application for a R25 YES is awarded while a P30 CURE Supplement is still active in the same institution, the P30 CURE Supplement will be terminated to allow the R25 award to be accepted.  Each institution may apply for more than one R25 YES grant, provided each R25 YES is distinct and unique.
Due Dates: Mar. 28 (OSR) Ι Mar. 30 (Sponsor)
Contact: Alison Lin, NCI Center to Reduce Cancer Health Disparities (CRCHD) - (linaj@mail.nih.gov)
Link: CRCHD Ι CURE


March 31 (LOI) Clinical Faculty (MDs) Non-federal Breast

Pfizer - Oncology
2016 ASPIRE Breast Cancer Research Awards Program

Pfizer is interested in supporting clinical studies of palbociclib in advanced breast cancer (See Scope of Research Areas.)  Projects are expected to yield results that will advance knowledge of palbociclib in treatment and disease management of advanced breast cancer.
Due Dates: Mar. 31 (Letter of Intent)
Announcement of investigators selected to submit full protocols for final decision: May, 2016
Amount & Project Period: ~$800,000 (TOTAL) - 24 to 30 months
Eligibility: Applicant (PI) must have a medical degree (MD or equivalent)
Contact: Office of Sponsored Research (x6804)
Link: 2016 ASPIRE Breast Cancer Research Awards Program


NEW
March 31 All Faculty Ranks Non-federal Head & Neck

Brandon C. Gromada Head & Neck Cancer Foundation
Research Awards

 
Awards are intended to stimulate innovative research regarding treatment and cures for head and neck cancers.
Due Dates: Mar. 29 (OSR) Ι Mar. 31, 5:00pm, (Sponsor)
Amount & Project Period: $10,000 to $20,000 (Total) - 2 years
Eligibility: All Faculty Ranks Funds may be used by junior investigators to support ongoing, unfunded projects, or by senior investigators as seed money to launch new initiatives
Contact: Office of Sponsored Research (x6804)
RFP Link: RFP


Semi-annual Deadline
April 01 See Below Non-federal Career Development

American Cancer Society
Research and Training Grants

Independent Investigators:     Research Scholar Grants
Mentored Research Grants:    Postdoctoral Fellowships Ι Mentored Research Scholar Grant
Due Dates: Mar. 30 (OSR) Ι Apr. 01 (Sponsor) NOTE:  Paper copies are due one day after submission of the electronic copy
Amount & Project Period: Research Scholar Grants: $165,000/yr. (Direct Costs) - 4 years   Postdoctoral Fellowships: Progressive stipends of $48,000, $50,000, and $52,000, plus a $4,000/yr. fellowship allowance - 3 years  
Mentored Research Scholar Grant: $135,000/yr. (Direct Costs) - 5 years
Eligibility: See specific Program Announcement
Contact: Office of Sponsored Research (x6804)
Links: Grant Types Ι Proposal Central (Submission Site)
 

Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families

Funding for investigators performing pilot and exploratory research studies whose purpose is to test interventions, develop research methodologies, and explore novel areas of research in palliative care of cancer patients and their families. A condition of funding is a clearly defined plan as to how the investigator will use the results of the project to develop larger, extramurally funded research projects.
Due Dates: Mar. 30 (OSR) Ι Apr. 01 (Sponsor) NOTE:  Paper copies are due one day after submission of the electronic copy
Amount & Project Period: $60,000/yr.  (Direct Costs ) - 2 years
Eligibility: Full-time faculty position or equivalent
Contact: Office of Sponsored Research (x6804)
Link: RFA

April 01 Junior Faculty Non-federal Lung

A Breath of Hope Lung Foundation
2016 Research Fellowships

Awards support one of two topics: (1) Developing knowledge, understanding and solutions for lung cancer in women or (2) Novel strategies for the early detection and/or screening of lung cancer.
Due Dates: Mar. 30 (OSR) Ι Apr. 01 (Sponsor)
Amount & Project Period: $150,000 - 2 years
Eligibility: Be w/in first 5 years of first faculty appointment;
Have a mentor who is lung cancer specialist;
Spend 50% effort on lung cancer research during award period.
Contact: Office of Sponsored Research (X6804)
Link: 2016 Announcement  
Eligibility Form(Note:  Eligibility form must be completed and submitted; before access to submission site is provided.)
A Breath of Hope Lung Foundation


April 01 All Ranks Non-federal Leukemia

When Everyone Survives (WES) Leukemia Research Foundation
2016 Request for Proposals in Leukemia Research

These awards provide support for laboratory, translational, or clinical research related to acute leukemia.
Due Dates: Mar. 30 (OSR) Ι Apr. 01 (Sponsor)
Amount & Project Period: $50,000 (TOTAL) - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Application Guidelines


April 01 Postdocs Non-federal Career Development

Cancer Research Institute
Postdoctoral Fellowships

The purpose is to support training in cancer immunology.  CRI seeks hypothesis-driven, mechanistic studies in both immunology and tumor immunology.
Due Dates: Mar. 30 (OSR) Ι Apr. 01 (Sponsor)
Amount & Project Period: Stipend:     $55,000 Year 01                                                
                    $57,000 Year 02                                                           
                    $59,000 Year 03 and                                                 
                    $1,500/year for research support
Eligibility: Must have a doctoral degree by award activation.  
Must have < 5 years of relevant postdoctoral experience.                                     
Contact: Office of Sponsored Research (x6804)
Link: Application Guidelines
U01 NCI

April 11 (LOI) All Ranks Federal Clinical Proteomic Tumor Analysis

Proteogenomic Translational Research Centers for Clinical Proteomic Tumor Analysis Consortium

This is part of the NCI Clinical Proteomic Tumor Analysis Consortium (CPTAC) that will support broad efforts focused on several cancer types to explore further the complexities of cancer proteomes and their connections to abnormalities in cancer genomes.  This FOA solicits applications for multidisciplinary Proteogenomic Translational Research Centers (PTRCs) that are intended to function as an interactive group focused on applying standardized state-of-the-art proteomic and genomic approaches to clinically-relevant research projects.
Due Dates:      Apr. 11 (Letter of Intent)
Applications Due: May 09 (OSR) Ι MAY 11 (Sponsor)
Amount & Project Period: $910,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-15-022
Companion RFAs: RFA-CA-15-021, U24 Resource-Related Research Project
RFA-CA-15-023, U24 Resource-Related Research Project


NEW
April 14 (Preliminary Proposal) All Ranks Federal STEM1

National Science Foundation (NSF)
Inclusion across the Nation of Communities of Learners of Underrepresented Discoverers in Engineering and Science (NSF INCLUDES)

 A comprehensive national initiative designed to enhance U.S. leadership in science, technology, engineering and mathematics (STEM1) discoveries and innovations focused on NSF's commitment to diversity, inclusion, and broadening participation in these fields. The initiative aims to improve the preparation, increase the participation, and ensure the contributions of individuals from groups that have traditionally been underrepresented and underserved in the STEM enterprise. Proposals are sought for "Design and Development Launch Pilots" to catalyze the formation of NSF INCLUDES Alliances.
Due Dates: Apr. 14 (Preliminary Proposal)
Invited Submissions: June 22 (OSR) | June 24 (Sponsor)
Amount & Project Period: $300,000 (TOTAL) - 2 years
Eligibility: All Ranks - The PI must hold a permanent position at the lead institution. The PI must have experience in leading distributed teams and organizations. Collaboration for impact in STEM relevant activities is desirable but not required.
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι  Program Solicitation Ι 1 STEM Education Act of 2015


NEW
April 15 Junior Faculty Moffitt Pilot Funding

American Cancer Society Institutional Research Grant (ACS-IRG)
Pilot Project Funding Opportunities

Pilot funding opportunities to support junior faculty in initiating cancer-related research projects that assist them in competing successfully for national research grants.
Due Dates: April 13 (OSR)   Proposals, accompanied by a Proposal Submission Form, are to be submitted to OSR for review at least 2 days prior to the deadline.  This is unique to investigators at Moffitt.  USF and Ponce investigators are to submit proposals directly to Maureen.Ahearn@moffitt.org
Amount & Project Period: $30,000 - 1 year
Eligibility: Eligible applicants at Moffitt, the University of South Florida (USF) and the Ponce School of Medicine (PSM) may apply.
Must be Full-time Asst. Member level or equivalent;
Must be w/in first 6 years of initial faculty appointment;
May not have active peer-reviewed funding at time of submission or award and investigators who have previously been awarded an R21, R01 or equivalent are not eligible; Research Scientists may be eligible to apply. Must be independent and w/in two years of a tenure-track appointment.
Please see guidelines for additional restrictions.
Contact: Maureen Ahearn (x8824)
Links: ACS-IRG Guidelines Spring 2016 
ACS-IRG Application Spring 2016
Admin. Supplement NCI

April 15 See Below Federal Pediatric Burkitt Lymphoma (BL)

Supplements to Promote Clinical Research Studies on Pediatric Burkitt Lymphoma in Low- and Middle-Income Countries

The Center for Global Health (CGH) at NCI seeks to promote clinical research studies on pediatric Burkitt Lymphoma (BL) in low- and middle-income countries (LMICs) through collaborations and research partnerships between NCI-designated Cancer Centers and partner institutions in LMICs. NCI will provide administrative supplement awards to currently funded P30 NCI-designated Cancer Center grants to support pilot research projects on pediatric BL. These partnerships are expected to improve diagnosis and treatment strategies to alleviate pediatric BL burden in LMICs.
Due Dates: Apr. 13 (OSR) Ι Apr. 15 (Sponsor)
Amount & Project Period: $100,000/yr.  (Direct Costs) -2 years (At least 60% of the proposed budget must be for costs at the LMIC institution.)
Eligibility: All Ranks Project & budget periods must be w/in currently approved project period for existing parent award. Proposed period may not include any anticipated period of no-cost extension of parent award. Project period must not exceed 24 months
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-086
U01 NCI

NEW
April 19 (LOI) All Ranks Federal Tissue Engineering

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research

This FOA will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Supported projects will establish and collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program.
Due Dates: Apr. 19 (Letter of Intent)
May 29 (OSR) | May 31 (Sponsor)
Additional Due Dates: Nov. 30; May 30 & Nov.30, 2017; and May 30 & Nov. 30, 2018 (all w/LOI due 6 weeks prior to due date)
Amount & Project Period: $400,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-105


NEW
April 19 Clinical Faculty Non-federal Career Development

Robert Wood Johnson Foundation
Clinical Scholars Program

This program provides a fellowship for clinically active health care providers spanning a range of disciplines. It aims to provide clinicians with the opportunity to build and develop the unique skills needed to lead communities toward a Culture of Health.  Strong applicants will bring a knowledge of and experience in the art and science of health care services, a unique perspective as providers on health and health care systems, and a special professional status and relationship with patients and communities.
Due Dates: Apr. 15 (OSR) Ι Apr. 19 (Sponsor)
Amount & Project Period: $105,000 - 3 years
Eligibility: Clinically active health care providers
Completed all required clinical training >5 years prior to applying;
Will be fully licensed in chosen profession or be doctorally prepared and have a clinical master's degree;
Have substantial community-focused research or program experience;
Must be U.S. citizens, permanent residents, or individuals granted DACA status.
Contact: Office of Sponsored Research (x6804)
Links: Overview  Ι 2016 Call for Applications

NEW
April 21 (Pre-application) See Below Federal Breast

Congressionally Directed Medical Research Programs
Breast Cancer Research Program

Due Dates: Apr. 21 (Pre-application)
Full Applications Due: May 03 (OSR) Ι May 05 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Links: FY16BCRP Ι https://eBRAP.org (Pre-app. submission site)

Breakthrough Fellowship Award (NEW!)
W81XWH-16-BCRPBREAKTHROUGH_FELLOWSHIP

Supports talented recent doctoral or medical graduates in pursuit of promising research having potential to lead to or make breakthroughs in breast cancer. Potential impact may be near-term or long-term, but must be significant and go beyond an incremental advancement. Individualized training program and mentorship should prepare PI for an independent career at the forefront of breast cancer research or patient care. PI is not required to have previous experience in breast cancer research.
Amount & Project Period: $300,000 (Direct Costs) - 3 years
Eligibility: As of application deadline candidate will have:
Successfully completed requirements for a doctoral or medical degree, and been in laboratory or clinical research setting in which proposed research is to be performed for no more than 2 years.
A total of less than 4 years' experience in a postdoctoral fellowship or mentored clinical research training program (excludes any clinical residency or fellowship training).
Mentor must have breast cancer research experience, including current funding and recent publications
NEW


Breakthrough Award Levels 1 and 2
W81XWH-16-BCRP-BREAKTHROUGH_FL12

Supports promising research that has potential to lead to or make breakthroughs in breast cancer. Potential impact may be near-term or long-term, but must be significant and go beyond an incremental advancement. Partnering PI Option allows 2 PIs (termed Initiating and Partnering PIs) to collaborate on a single application.
Amount & Project Period: Requested funding level should be based on scope of research proposed.
Level 1:  $375,000 (Direct Costs) - 3 years
Level 1 (Ptnr. PI):  $600,000 (Direct Costs) - 3 years (A separate award will be made to each PI's institution.)
Level 2:  $750,000 - 3 years
Level 2 (Ptnr. PI):  $1.0M - 3 years (A separate award will be made to each PI's institution.)
Eligibility: Investigators at all academic levels (or equiv.) Senior postdoctoral fellows who do not meet the eligibility requirements of the Breakthrough Fellowship Award are encouraged to apply under Funding Levels 1 and 2.
NEW


Era of Hope Scholar Award
W81XWH-16-BCRP-EOHS

Supports talented, creative early-career scientists Proposals should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention. PIs should exhibit strong potential for leadership in the breast cancer community.
Amount & Project Period: $2.5M (Direct Costs) - 4 years
Eligibility: Independent, non-mentored investigators w/in 6 years of last training position (e.g., postdoctoral fellowship, medical residency, clinical fellowship) as of application submission deadline

NEW
April 22, 5:00 Women & Minority Investigators Non-federal Cutaneous Malignancies

Moffitt Skin Cancer SPORE
Career Enhancement Program & Developmental Research Program

Developmental Research Program (DRP) The DRP promotes the exploration of innovative ideas in translational cutaneous malignancy research through the funding of pilot projects.
Career Enhancement Program (CEP) The CEP will be used to prepare female and/or minority investigators at the rank of Assistant Member particular those already in the field of cutaneous malignancy research, or established investigators at the rank of Associate Member or higher who are new to the field for careers in translational research of cutaneous malignancies. 
Due Dates: Apr. 22, (5:00 pm)
Email applications to awards@moffitt.org, Office of Sponsored Research at least two days prior to the deadline
Amount & Project Period: Amount awarded will depend on costs of science proposed, innovation, and potential for further funding of research.  Performance period is one (1) year.
Eligibility: Investigators must be female and/or of racial or ethnic minority as defined by the NIH.
Links: Updated Guidelines  Ι  Updated Application 

NEW
April 22 (LOI) All Faculty Non-federal Lung

Free to Breathe
2016 Metastasis Research Grant  To Prevent or Stop Lung Cancer Metastasis

Letters of Intent (LOI) are solicited that propose research to prevent or stop lung cancer metastasis and include a clear vision and plan for clinical translation.   Awards will support high-impact, innovative lung cancer research within this area of emphasis that will result in clinical translation (e.g. clinical trial).   Proposals with interdisciplinary, collaborative teams and two or more PIs are encouraged.
Due Dates: Apr. 22, 5:00pm (EST) (Letter of Intent)
Invited Submissions:  Aug. 13 (OSR) Ι Aug. 15 (Sponsor)
Amount & Project Period: $600,000 (TOTAL) - 3 years
Eligibility: Must be independent investigators at or above the level of Assistant Professor (or equivalent)
Need not be US citizen; however work visa verification required Applications only accepted from PIs engaged in non-small cell or small cell lung cancer research
Contact: Office of Sponsored Research - (x6804)
Links: Overview Ι RFP Ι Submission Site
R25 NIH
Education Project
April 25 (LOI) All Ranks Federal Genomics

Initiative to Maximize Research Education in Genomics: Courses

The over-arching goal of this NHGRI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral and clinical research needs.by supporting short, advanced level courses that are intended to disseminate new techniques, methods, and analyses related to the mission of the NHGRI. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development.
Due Dates: Apr. 25 (Letter of Intent)
May 23 (OSR) Ι May 25 (Sponsor)
Additional Dates:  Sept. 25 & Jan. 25
Amount & Project Period: $50,000 (Direct Costs) An additional $5,000 in direct costs may be requested for the specific purpose of video recordings of lectures and/or hands on demonstrations - 3 years
Eligibility: The PD/PI should be an established investigator in the scientific area in which the application is targeted and capable of providing both administrative and scientific leadership to the development and implementation of the proposed program. The PD/PI is expected to monitor & assess the program and submit all documents & reports as required.
Contact: Office of Sponsored Research (x6804)
FOA  Link: PAR-16-090


April 26 Postdocs/Fellows/Junior Faculty Non-federal Career Development

Multiple Myeloma Research Foundation (MMRF)
2016 Research Fellow Award

The goal of this initiative is to help support young investigators to begin their studies in the field of multiple myeloma while advancing the understanding of myeloma disease biology, treatment and drug resistance.
Due Dates: Apr. 24 (OSR) Ι Apr. 26 (Sponsor)
Amount & Project Period: $75,000/yr. - 1 year
Eligibility: Post-doctorate, clinical fellow, or junior faculty levels are eligible and must work under the supervision of a research mentor/sponsor in the multiple myeloma field.
Contact: Office of Sponsored Research  (x6804)
Links: Guidelines | proposalCentral (Submission Site)
Admin. Supplement NCI
Division of Cancer Control and Population Sciences (DCCPS)

NEW
April 27 See Below Federal Health Disparities/Equity Research

Administrative Supplements for Collection and Analysis of Data and Biospecimens for Health Disparities/Equity Research

NCI's Division of Cancer Control and Population Sciences (DCCPS) announces an opportunity for supplemental funding to support:
(1) collection of new data (including linkages to other relevant databases or biospecimens) to augment existing study data;
(2) analysis of existing data addressing research gaps in cancer health disparities/equity; and
(3) exploratory research or research activities to strengthen the ability of existing studies to address research gaps in health disparities research and studies of understudied populations (rural, low SES, racial and ethnic groups).
Due Dates: Apr. 25 (OSR) Ι Apr. 27 (Sponsor)
Amount & Project Period: $150,000 (TOTAL) - 1 year
Eligibility: PIs can submit 1 administrative supplement per study
PI must have active R21, R01, P01, U01, or UM1 grant supported through NCI DCCPS. No other grant mechanisms are eligible for this program.
Parent grant must have sufficient time remaining to accommodate supplement. At least 1 full year must remain on the grant at the time of funding. Requests for no-cost extensions on the parent grant to accommodate a supplement will not be permitted.
Contact: Office of Sponsored Research  (x6804)
Link: Guidelines

NEW
April 27 (Pre-application) See Below Federal Breast

Congressionally Directed Medical Research Programs
Breast Cancer Research Program
Due Dates: Apr. 27 (Pre-application)
Invited Submissions: Aug. 09 (OSR) Ι Aug. 11 (Sponsor)
Contact: Office of Sponsored Research (x6804)
RFA Link: FY16BCRP | https://eBRAP.org (Pre-app. submission site)

Breakthrough Award Levels 3 & 4
W81XWH-16-BCRP-BREAKTHROUGH_FL34

Supports promising research having potential to lead to or make breakthroughs in breast cancer. Potential impact may be near-term or long-term, but must be significant and go beyond an incremental advancement. Partnering PI Option allows 2 PIs (Initiating and Partnering), to collaborate on a single application.
Amount & Project Period: The funding level should be selected based on scope of research project.
Level 3:  $2.5M (Direct Costs) - 4 years
Level 3 (Ptnr. PI):  $4.0M - 4 years (Separate awards made to each PI's institution)
Level 4 (Single or Ptnr. PI):  $10.0M - 4 years
Notes: An invited oral presentation is a requirement for application review of Funding Level 4 projects. Research milestones to be accomplished by the end of each year in the period of performance must be clearly defined in the project SOW and will be finalized during award negotiations.
Eligibility: All Ranks - Independent Investigators at all academic levels (or equiv.)

NEW


Innovator Award
W81XWH-16-BCRP-INNOV

Supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field. Provides opportunity to pursue novel, visionary, high-risk ideas that will accelerate progress toward ending breast cancer. PIs must include breast cancer advocates on their research team.
Amount & Project Period: $5M (Direct Costs) - 4  years
Eligibility: Associate Professor or above (or equiv.);
PI must maintain 50% full-time effort during award period to breast cancer research;
Previous recipients of the BCRP Innovator Award are ineligible.
NEW


Distinguished Investigator Award
W81XWH-16-BCRP-DIA

Seeks new paradigms in breast cancer research by supporting investigators who are established and recognized leaders in their field and who propose a fundamental shift or leap beyond their existing track record of research.
Amount & Project Period: $3M (Direct Costs) - 4 years
Note:  Travel costs for PI to disseminate project results at DoD-required meeting in Yrs. 1 & 3. It should be assumed that meeting will be held in National Capital Area.
Eligibility: Assistant Professor or above (or equiv.)
Must be >6 years beyond last training position as of application submission deadline
Must include two or more breast cancer advocates on research team.
U01 NIH

NEW
April 27 (LOI) All Ranks Federal Cancer care Delivery

Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests

This FOA encourages applications that strengthen the science of multilevel effects of cancer care interventions by addressing the problem of incomplete follow-up to abnormal screening tests for breast, colorectal, cervical and lung cancers.
Due Dates: Apr. 27 (Letter of Intent)
May 24 (OSR) Ι May 26 (Sponsor)
Additional Dates:  Sept. 21; May 26 & Sept. 21, 2017
Amount & Project Period: $450,000 to $500,000/yr. (Direct Costs) - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-108

NEW
April 29, 3:00pm (EDT) All Faculty Non-federal Prostate Cancer

Prevent Cancer Foundation (PCF)  
2016 Challenge Awards  
For investigations of metastatic, lethal prostate cancer

 Research proposals in the following topic areas are preferred:
1.    New systemic treatments for metastatic, lethal prostate cancer incl. those targeting the 
       currently 'undruggable'.
2.    First-in-field research on new targets for systemic treatment of metastatic, lethal prostate
        cancer.
3.    Mechanisms of resistance to current and investigational drugs targeting the androgen
        receptor and androgen axis, immune system and chemotherapy.
4.    Correlative research around either clinical trials of novel agents or strategies or standard
        of care.
5.    Developing/validating biomarkers guiding therapy in patients or further understanding of
       mechanisms by which therapies work.
6.    Tumor microenvironment signaling related to cancer progression including the immune
       component.
7.    New bioinformatics technologies for analysis of genomic data.

Note:  A team is assembling for a Challenge Award submission on Immunotherapy of Prostate Cancer that will be co-funded by the V Foundation.  Please contact Dr. Julio Pow-Sang for information.
Due Dates: Apr. 27 (OSR) Ι Apr. 29, 3:00pm (EDT) (Sponsor)
Amount & Project Period: $1,000,000 (TOTAL) - 2 years
Eligibility: Teams are composed of at least three (3) investigators, including one young investigator
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι RFA Ι Submission Site


April 29 All Faculty Non-federal Basic & Translational

Worldwide Cancer Research (formerly AICR)
Research Grants

To support research that might help reduce the incidence of cancer or improve cancer survival.  Projects are awarded for fundamental or translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer.
Due Dates: Apr. 27 (OSR) Ι Apr. 29 (Sponsor)
Amount & Project Period: Max. £250,000 ($370,557 as of 12/22/2015) - 1 to 3 years
Eligibility: PI must be a suitably qualified researcher (minimum of PhD with 3 to 10  years research experience, or equivalent qualification or research experience, and usually a qualified tenured or tenure-track research group leader).
Contact: Office of Sponsored Research (x6804)
Link: Make an Application


NEW
April 30 All Ranks Non-Federal Career Development

Chest Foundation

Due Dates: April 28 (OSR) Ι May 02 (Sponsor)
Eligibility: All Faculty Ranks
CHEST membership required at time of application.
Special consideration given to those w/in 5 years of completing an advanced training program.
Contact: Office of Sponsored Research (x6804)
Links: 2016 RFPs Ι Application Site

Research Grant in Lung Cancer
Supported by Genentech, Inc.

Award to support a research a project in lung cancer that leads to improved medical and/or surgical detection, treatment, and/or cure of lung cancer.  Higher level translational research project is preferred.  Basic (cellular/animal) research projects will not be considered.
Amount & Project Period: $90,000 (Total) - 2 years
NEW

Research Grant in Women's Lung Health
Supported in full by the CHEST Foundation

Responsive applications will address important and timely issues surrounding women's lung health, including  diseases such as COPD and lung cancer.
Amount & Project Period: $10,000 - 1 year

NEW
May 6, 4:00pm Junior Faculty Moffitt Pilot Projects

MMG Junior Faculty Research Award

The MMG Junior Faculty Research Award (JFRA) is intended to ease the transition to independence for investigators either in the laboratory or as clinical trialists. The goal is to allow appropriate and motivated individuals to develop an independent research career in translational science focused on cancer.  It is intended that the MMG Junior Faculty Research Award will be used for research directly related to cancer investigation and must be translational or clinical in nature.
Due Dates: Friday, May 6, 2016 at 4:00pm EST
Amount & Project Period: $50,000 - 1 year
Eligibility: Instructor and Assistant Member levels
Contact: Jill Cass at Jill.Cass@moffitt.org or call 745-1387
Links: JFRA Guidelines  Ι  JFRA Application
R01 NIH
NCI is a participating Institute
May 07 All Ranks Federal Malignancies and HIV/AIDS

Research on Malignancies in the Context of HIV/AIDS

Research is encouraged in areas such as the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both non-AIDS defining and AIDS-defining malignancies in diverse populations. This FOA encourages research efforts that will (i) provide information on the clinical outcomes of such cancers in the HIV-infected population and (ii) identify specific contributions resulting from HIV infection and its potential interaction with other pathogens for the development and pathogenesis of these cancers.
Due Dates: May 05 (OSR) Ι May 07 (Sponsor)
Additional Dates:  September 07 & January 07
Amount & Project Period: Budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-13-377
Companion FOA: PA-13-378  R21 Exploratory/Developmental Grant
R01 NIH
NCI is a participating Institute
May 07 All Ranks Federal HIV and Viral Hepatitis Co-Infection

Multidisciplinary Studies of HIV and Viral Hepatitis Co-Infection

The purpose is to fill gaps in our understanding of a) the pathogenic interactions between HIV and hepatitis viruses, b) co-morbidities associated with HIV/hepatitis virus co-infection, and c) the effectiveness of interferon-free direct-acting antiviral drug regimens to treat HIV/HCV co-infection.
Due Dates: May 05 (OSR) Ι May 07 (Sponsor)
Additional Dates:  September 07 & January 07
Amount & Project Period: Budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-14-255
Companion FOA: PAR-14-254  R21 Exploratory/Developmental Grant

NEW
May 11, 2:30pm, ET All Ranks Non-federal Global Health

Bill & Melinda Gates foundation
Global Grand Challenges
Grand Challenges Explorations Explore New Solutions in Global Health Priority Areas

Seeking innovative ideas to assess the burden of disease, to develop better vaccines, and to develop new diagnostics, to, among other challenges, enable self-testing for cervical cancer by seeking biomarkers that can be measured in simple-to-collect cervical, vaginal and urine specimens to diagnose women with cervical cancer or pre-cancer (histologically confirmed CIN2+ or higher lesions) in a screening population.  Preferred biomarkers will have preliminary clinical evidence that targeted biomarkers are non-inferior to current validated biomarkers, and can be reliably measured in less than two hours with minimal instrumentation and operator processing.
Due Dates: May. 09 (OSR) Ι May 11, 2:30pm, ET (Sponsor)
Amount & Project Period: $100,000 - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: The Opportunity Ι Application Instructions
Grant Application Tool Ι Rules & Guidelines



NEW
May 13, 12:00 (EDT) All Faculty Non-federal Myelodysplastic Syndromes

The Taub Foundation
Grants Program for Myelodysplastic Syndromes (MDS) Research

 Supports high-impact, innovative translational research to understand underlying causes of MDS and to advance treatment and prevention.  The Program specifically focuses on MDS research, exclusive of AML and MPN.  Studies focusing on molecular genetics, epigenetics, splicing factors, stem cells, the microenvironment and novel therapeutic targets relevant to MDS are encouraged.
Due Dates: May 11 (OSR) Ι May 13, 12:00 (EDT) (Sponsor)
Amount & Project Period: $600,000 (TOTAL) - 3 years
Eligibility: Must hold  Ph.D., M.D., M.D./Ph.D., or equivalent degree
Must be independent investigators w/institutional support and their own laboratory
May not have funding support for a similar project U.S. Citizenship is not required; visa documentation is not required
Contact: Office of Sponsored Research (x6804)
Links: Overview | Online Portal for Application

NOTE:  From March 24 through approximately April 4, 2016, you will not be able to start a new online application due to updates in our software program. You will still be able to access your account page, work on a saved application and/or submit your application.
S10 NIH

May 16 All Ranks Federal Equipment

Shared Instrumentation Grant (SIG) Program

This FOA encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $50,000.
Due Dates: May 14 (OSR) Ι May 16 (Sponsor)
Amount & Project Period: $600,000 (Max. Award) - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-054
S10 NIH

May 16 All Ranks Federal Equipment

High-End Instrumentation (HEI) Grant Program

This FOA encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $600,000.
Due Dates: May 14 (OSR) Ι May 16 (Sponsor)
Amount & Project Period: $2,000,000 (Max. Award) - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804) 
RFA Link: PAR-16-053
U01 NIBIB
NCI is a participating institute

NEW
May 18 All Ranks Federal Diagnosis & Treatment

Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment

FOA is accepting bioengineering applications to accelerate development and adoption of promising tools and technologies that can address important biomedical problems.  Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies, and engage biomedical researchers or clinicians throughout the project.  The goal of the program is to support projects that can realize meaningful solutions within 5 - 10 years.
Due Dates: May16 (OSR) | May 18 (Sponsor)
Additional 2016 Due Dates:  Sept. 13
Amount & Project Period: Application budget not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research - (x6804)
FOA Link: PAR-16-116
Companion FOAs: PAR-13-137, R01 Bioengineering Research Grants (BRG)
PA-16-040,   R21 Exploratory/Developmental Bioengineering Research Grants (EBRG)
R25 NCI
Cycle II Due Date
May 25 Associate/Full Members Federal Cancer Education

Cancer Education Grants Program  Curriculum or Methods Development

This FOA will support creative educational activities with a primary focus on Curriculum or Methods Development.   Applications that propose innovative, state-of-the-art programs, addressing the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients are encouraged.
Due Dates: May 23 (OSR) Ι May 25 (Sponsor)
Additional 2016 Due Date:  Sept. 25
Amount & Project Period: $100,000/year (Direct Costs) - 3 years
Eligibility: Established investigator at Associate Professor level or above in scientific area in which application is targeted, and capable of providing both administrative and scientific leadership to development and implementation of proposed program.
PD(s)/PI(s) with a currently funded NCI R25 award may submit an additional application in response to this FOA only if a new and innovative course that is distinctly different from the currently funded project is proposed.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-150
Companion FOAs: PAR-15-151, R25-Cancer Research Education Grants Program: Courses for Skills Development
PAR-15-152, R25-Cancer Research Education Grants Program:  Research Experiences
U01 NCI

NEW
May 25 (LOI) All Ranks Federal Cancer Systems Biology

Emerging Questions in Cancer Systems Biology

This FOA solicits well-defined, discrete and circumscribed Research Projects addressing emerging problems in cancer as a part of a new Cancer Systems Biology Consortium (CSBC).  The consortium will include U54 CSBC Research Centers and a U24 CSBC Coordinating Center (see companion opportunities below). The CSBC initiative aims to address challenges in cancer Research through the use of experimental biology or population science combined with in silico modeling, multi-dimensional data analysis , and systems engineering.
Due Dates: May 25 (Letter of Intent)
June 22 (OSR) Ι June 24 (Sponsor)
Additional 2016 Due Date: Nov. 18
Amount & Project Period: Application budget not limited - 5 years
Eligibility: All Ranks 
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-131
Companion Opportunities: RFA-CA-15-014 U54 Research Centers for Cancer Systems Biology Consortium
RFA-CA-15-015 U24 Coordinating Center for the Cancer Systems Biology Consortium and the Physical Sciences-Oncology Network


NEW
May 30 All Faculty Non-federal Translational

Rising Tide Foundation for Clinical Cancer Research
Clinical Cancer Research

The overall goal of this cancer research funding program is to improve treatment options and quality of life for cancer patients by funding clinical studies focused on prevention, detection, treatments and aftercare.   It funds early stages clinical studies and translational research that can demonstrate the potential for quick and meaningful impact.
Due Dates: May 30 (Letter of Intent) to be included in second funding cycle.  LOIs may be submitted at any time and date of receipt determines timing of review. If proposed project meets RTF funding criteria, an invitation will be sent to submit a full grant application for further consideration.
Amount & Project Period: Amount is based on the availability of funds. Duration is up to five years or less.
Eligibility: All Faculty
Contact: Office of Sponsored Research (x6804)
Links: Overview - How to Apply
Clinical Cancer Research Programmatic Guidelines
Proposal Central (Submission site)


NEW
May 31 ALL Ranks Non-federal Culture of Health

Robert Wood Johnson Foundation
Global Ideas for U.S Solutions

Looking for projects, programs, and models that promote health equity and are aligned with our Culture of Health Action Framework; current year interests in ideas that: Build healthy places; Build social connection across the lifespan; Get and keep children healthy; Integrate health and social services; and Increase the health care system's focus on the root causes of poor health.
Due Dates: May 27 (OSR) I May 31 (Sponsor)
March 30 (11am-12pm. ET) :  Webinar for prospective applicants. Registration is required; use this link.
Amount & Project Period: $50,000 up to $250,000 -  up to 18 months
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι Guidelines
U01 NIH

NEW
May 31 (LOI) All Ranks Federal Combined Modality Treatment
 of Solid Tumors

Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy

 For studies to enhance pre-clinical in vitro and in vivo testing of NCI-prioritized molecularly targeted anti-cancer agents for use with radiation therapy combined with systemic chemotherapy. ..The overall goal is to accelerate the pace at which combined modality treatments with greater efficacy are identified and incorporated into standard practices for treatments of patients with solid tumors.
Due Dates: May 31 (Letter of Intent)
Full Applications: Jul. 12 (OSR) | Jul. 14 (Sponsor)
Additional Due Dates: Dec. 14; Jul 14 & Dec. 14, 2017
Amount & Project Period: Not to exceed $450,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-111

and


Updated
June 02 All Ranks Non-federal Pediatric Brain Cancer

The Cure Starts Now Foundation
Research Grants

Funds search for a cure for brainstem glioma and other forms of pediatric brain cancer in the hopes of curing all cancers Focus is on Diffuse Intrinsic Brainstem Glioma (DIPG), and to support translational and clinical research projects in those areas.
Due Dates: May 30 (OSR) Ι June 01 (Sponsor) Ι Hardcopy due June 05
Amount & Project Period: $100,000 (TOTAL) - 1 year
Eligibility: All Ranks
Contact: Mary Newton (x3658) for writing assistance. 
All completed applications must be approved and submitted through the Office of Sponsored Research (x6804).
Links: Research & Grants
Grant Application Information
Electronic Submission
R01 NIH

NEW
June 06 All Ranks Federal Physical Activity/Weight Control

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival

This FOA encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival.
Due Dates: June 03 (OSR Ι June 06 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Budget not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-122
Companion FOA: PAR-16-123 (R21)
R01 NCI

NEW
June 06 All Ranks Federal Diagnosis & Treatment

Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment

Applications are encouraged from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for preclinical or clinical molecular diagnosis or in vitro imaging that are designed to solve a targeted cancer problem.  Partnership on each application should establish an inter-disciplinary, multi-institutional research team to work in strategic alliance to implement a coherent strategy to develop and translate their system to solve their chosen cancer problem.  FOA will support clinical trials that test functionality, optimize, and validate the performance of the proposed translational work.
Due Dates: June 03 (OSR) Ι June 06 (Sponsor)
Additional Due Dates:  Standard dates apply
Amount & Project Period: Application budget not limited - 5 years
Eligibility: All Ranks 
Contact: Office of Sponsored Research - (x6804)
FOA Link: PAR-15-075


NEW
June 06 All Faculty Non-federal Translational Research

The Harrington  Discovery Institute
Scholar-Innovator Award

 The Harrington Scholar-Innovator Award recognizes physician-scientist innovators throughout the U.S. whose research has the potential to change standard of care. The Scholar-Innovator Award provides research and drug development funding as well as non-financial support to selected innovators and their institutions to help bridge the gap between basic discovery and clinical introduction.
Due Dates: June 2 (OSR) Ι June 6 (Sponsor)
Submissions will be completed online at HarringtonDiscovery.SmartSimple.com
Amount & Project Period: $100,000  - 1 year.   See program description for additional information
Eligibility: Hold an MD or MD/PhD;
Hold a faculty position;
May have only a single PI;
Past recipients of the Harrington Scholar-Innovator Awards may submit new & distinct proposal but may not seek additional support for previously funded projects.
Contact: Office of Sponsored Research, x6804
Links: Overview Ι Grant Program Details Ι Program Policies
U01 NCI
Research Projects-Cooperative Agreement

 
June 11 (LOI) All Ranks Federal Imaging & Biomarkers

Imaging and Biomarkers for Early Detection of Aggressive Cancer

This FOA invites applications for collaborative research projects to improve cancer screening, early detection of aggressive cancer, assessment of cancer risk and cancer diagnosis aimed at integrating multi-modality imaging strategies and multiplexed biomarker methodologies into a singular complementary approach.
Due Dates: June 11 (Letter of Intent)
Jul. 09 (OSR) Ι Jul. 11 (Sponsor)
Additional Due Date in 2016:  Dec.14
Amount & Project Period: Budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-089
R01 NCI

June 21 All Ranks Federal Drug Delivery

Image-guided Drug Delivery

Funding will support innovative research projects that are focused on image-guided drug delivery (IGDD), including real-time image guidance, monitoring, quantitative in vivo characterizations and validation of delivery and response.  It will support research in development of integrated imaging-based systems for delivery of drugs or biologics in cancer and other diseases, quantitative imaging assays of drug delivery, and early intervention.
Due Dates: June 19 (OSR) Ι June 21 (Sponsor)
Note: Additional due date in 2016:  November 22
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6071)
FOA Link: PAR-16-044
R21 NCI

June 22 All Ranks Federal Career Development

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research

Supports eligible investigators from groups that have been shown to be underrepresented in the biomedical, clinical, behavioral, and social sciences workforce, and provides a bridge to investigators that have completed their research training and may need extra time to develop a larger research project grant application.
Due Dates: June 18 (OSR) Ι June 22 (Sponsor)
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6071)
FOA Link: PAR-15-053


June 30 All Faculty Non-federal Children's Leukemia

Children's Leukemia Research Association (CLRA)
Research Grants

These research grants are for doctors who are conducting the most promising research into leukemia, in the hopes of isolating the causes and finding a cure for this dread disease.
Due Dates: Mar. 02 (OSR) Ι Mar. 04 (Sponsor)
Amount & Project Period: $30,000 - 1 year
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview and Application


NEW
July 01 Junior Clinical Faculty Non-federal Career Development

Damon Runyon Cancer Research Foundation
Rachleff Innovation Award

The goal is to fund high-risk/high-reward research that lacks sufficient preliminary data to secure traditional funding.
Due Dates: June 29 (OSR) Ι July 01 (Sponsor)
Amount & Project Period: $300,000 (Total) - 2 years
Note: Continued support for years 3 and 4 will be granted to those awardees who demonstrate progress on their proposed research during years 1 and 2.
Eligibility: Applicants must belong to 1 of the following:
Tenure-track Assistant Professors w/in first 4 years of initial Asst. Professor appt. (Cut-off date: July 1, 2012.)
Clinical Instructors and Senior Clinical Fellows (in final year of sub-specialty training) holding an MD who are pursuing a period of independent research before taking a tenure-track faculty position.  Such individuals must have an exceptional record of research accomplishment, dedicated laboratory space and support of their institution.
Note: Research Assistant Professors, Research Associate Professors, Research Scientists and Postdoctoral Fellows are not eligible. 
Applicants are expected to commit a minimum of 80% effort to research
Contact: Office of Sponsored Research (x6804)
Link: Application Guidelines

NEW
July 01 All Ranks Non-federal Cutaneous

American Society for Dermatologic Surgery
Cutting Edge Research Grant Program (CERG)  

Submission of well-conceived research projects is encouraged.  Specifically encouraged are proposals in the areas of depth of training, scope of practice, safety and efficacy as well as research with specific relevance in:  Cosmetic medicine and surgery; Core surgical procedures and techniques; Cutaneous oncology; and  new technologies.
Due Dates: June 29 (OSR) Ι Jul. 01(Sponsor)
Amount & Project Period: $20,000 - 1 year
Eligibility: All Ranks;
PD/PI must be ASDS member
Contact: Office of Sponsored Research, x6804
Links: Overview Ι 2016 Application Site




NEW
July 01 All Ranks Non-Federal Clinical Oncology

The Hope Foundation
Early Exploration and Development (SEED) Fund

To encourage preliminary research that will translate to clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN).  Awards may assist investigators with projects that support the following types of studies: pre-clinical data, secondary data analysis from clinical trials, pilot and feasibility studies (including early stage clinical trials), small, self-contained research projects, or development of research methodology/technology.
Due Dates: June. 29 (OSR) Ι Jul. 01. 5:00, pm ET) (Sponsor)
Additional Due Date:  December 01
Amount & Project Period: $50,000/yr. - 2 years
Eligibility: Any SWOG investigator
Contact: Office of Sponsored Research (x6804)
RFA Link: Research & Funding Ι Announcement
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org